Aug 19, 2022 9:29am EDT Vyant Bio Announces Rescheduled Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
Aug 11, 2022 8:00am EDT Vyant Bio Announces Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
Jun 01, 2022 6:05pm EDT Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
May 19, 2022 8:30am EDT Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference
May 16, 2022 8:30am EDT Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights
May 10, 2022 4:01pm EDT Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
May 05, 2022 4:30pm EDT Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
Mar 30, 2022 7:50am EDT Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
Mar 29, 2022 5:00pm EDT Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
